ACT Capital Management »

Marker Therapeutics Ord shares owned by ACT Capital Management

Quarter-by-quarter ownership of Marker Therapeutics Ord shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Marker Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Marker Therapeutics Ord held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marker Therapeutics Ord by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2022-09-30 $131k 354k 0.37
2022-06-30 $117k 354k 0.33
2022-03-31 $156k 354k 0.44
2021-12-31 $337k 354k 0.95
2021-09-30 $743k 439k 1.69
2021-06-30 $1.2M 420k 2.79

More positions owned by ACT Capital Management

STAAR Surgical Company (STAA)
Exxon Mobil Corporation (XOM)
Devon Energy Corporation (DVN)
Krystal Biotech (KRYS)
Arrowhead Pharmaceuticals (ARWR)
Axsome Therapeutics (AXSM)
Chevron Corporation (CVX)
Adtran Holdings (ADTN)
Envveno Medical (NVNO)
Clearside Biomedical (CLSD)
Laredo Petroleum (VTLE)
Arcturus Therapeutics Hldg I (ARCT)
Eiger Biopharmaceuticals
Verona Pharma Sponsored Ads (VRNA)
Energy Transfer Com Ut Ltd Ptn (ET)

View all positions for ACT Capital Management

Top funds holding Marker Therapeutics Ord

AR Asset Management

View all funds holding Marker Therapeutics Ord